Nojoto: Largest Storytelling Platform
Download Nojoto

Install App Get upto ₹ 100 Cash

Japan team develops COVID treatment using syntheti

Japan team develops COVID treatment using synthetic immune cells A research team in Japan has developed immune cells using embryonic stem cells of human origin to treat novel coronavirus infections. The research team, including members from Kyoto University and Fujita Health University, plans to conduct a clinical trial in three years on patients who became immunocompromised due to chemotherapy and are suffering severe symptoms of COVID-19, it said in late July. The team artificially created cytotoxic T cells, known as "killer T cells," that attack cells infected with a virus. The cells, developed in a way to reduce the risk of rejection by patients, have genes with "sensor" functions to detect the proteins unique to the novel coronavirus. ©SHIRSENDU KARMAKAR #Covid
shirsendukarmaka6666

SHIRSENDU KARMAKAR

New Creator
streak icon25

#COVID #Motivational

162 Views